Category - Executive Moves

Executive Moves

Novelion Therapeutics CEO Mary Szela resigns

Novelion Therapeutics (NASDAQ:NVLN) CEO, Mary Szela, has resigned for personal reasons, effective immediately, and the company has begun a search for a new CEO.

November 9, 2017

Executive Moves

Jeffrey Kadanoff joins Synergy as CFO

Synergy CHC (OTCQB:SNYR) appointed Jeffrey Kadanoff as its CFO, effective Nov, 1, 2017.

October 16, 2017

Executive Moves

Tom Wright joins Ortho RTi board

Ortho Regenerative Technologies appointed global sports and entertainment veteran, Tom Wright, to the board.

October 3, 2017

Executive Moves

Roth expands healthcare research team

Dr. Jotin Marango and Yasmeen Rahimi have joined the healthcare research team at Roth Capital Partners.

September 20, 2017

Executive Moves

Ortho RTi CSO appointed bioengineering chair at George Mason

Ortho Regenerative Technologies said its chief scientific officer, Michael Buschmann, has been appointed as bioengineering chair, professor and eminent scholar (an award from Virginia’s Center for Innovative...

September 7, 2017

Executive Moves

Vital Therapies names Faheem Hasnain as chairman

Vital Therapies (NASDAQ:VTL) appointed Faheem Hasnain as chairman, effective immediately.

September 6, 2017

Executive Moves

Ortho RTi names François-Xavier Lacasse as VP product development

Ortho Regenerative Technologies appointed François-Xavier Lacasse to the newly created position of VP of product development. Dr. Lacasse’s mandate will be development and execution of a comprehensive product...

August 29, 2017

Executive Moves

Zymeworks names Dr. Natalie Sacks to board

Zymeworks (NYSE:ZYME; TSX:ZYME) appointed Dr. Natalie Sacks, who has served as CMO of Aduro Biotech since Sept. 2016, to its board.

August 3, 2017

Executive Moves

Microbix appoints Cameron Groome as President, CEO

Microbix Biosystems (TSX:MBX) has appointed Cameron Groome as its president and CEO, with Vaughn Embro-Pantalony retiring from those positions but remaining an executive director, working closely with Mr. Groome to...

July 24, 2017

Executive Moves

James Antonopoulos joins Roth in healthcare banking

James Antonopoulos has joined Roth Capital Partners as managing director, co-head of healthcare investment banking.

June 28, 2017

Category - Executive Moves

Novelion Therapeutics CEO Mary Szela resigns

Jeffrey Kadanoff joins Synergy as CFO

Tom Wright joins Ortho RTi board

Roth expands healthcare research team

Ortho RTi CSO appointed bioengineering chair at George Mason

Vital Therapies names Faheem Hasnain as chairman

Ortho RTi names François-Xavier Lacasse as VP product development

Zymeworks names Dr. Natalie Sacks to board

Microbix appoints Cameron Groome as President, CEO

James Antonopoulos joins Roth in healthcare banking

General

More